Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies.

To estimate the striatal uptake constant of [18F]-L-6-fluorodopa (FDOPA) in humans, we studied two methods that can account for the image resolution and the background level of FDOPA. These two methods utilize information obtained from multiple ROIs varying in size around the putamen and from profiles crossing the middle of the putamen. The estimation of the uptake constant was based on a model of one-dimensional activity variation. Simulated data were used to evaluate the adequacy of these two methods. Parametric images of FDOPA uptake constants were generated using Patlak analysis for five studies in normals and were then analyzed with the two methods. Results from the simulated data indicated a good agreement between the estimated values and the true simulated values. Results from studies in normals show stable estimates of the FDOPA uptake constant that are not affected by image resolution. The two methods were not sensitive to the misplacement of ROIs and profiles.

[1]  M. Bergstrom,et al.  Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism. , 1987, Advances in neurology.

[2]  B. Pate,et al.  The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  J. Hoffman,et al.  6-[18F]Fluoro-l-DOPA metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography , 1991, Brain Research.

[4]  M. Phelps,et al.  Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  B. Mazoyer,et al.  Kinetic data analysis with a noisy input function. , 1987, Physics in medicine and biology.

[7]  Scott T. Grafton,et al.  Kinetics and Modeling of l-6-[18F]Fluoro-DOPA in Human Positron Emission Tomographic Studies , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  S. Gambhir Quantitation of the physical factors affecting the tracer kinetic modeling of cardiac positron emission tomography data , 1990 .

[9]  K. L. Leenders,et al.  Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers , 1988, Brain Research.

[10]  C. Patlak,et al.  Nigrostriatal function in humans studied with positron emission tomography , 1989, Annals of neurology.

[11]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.

[12]  J R Moeller,et al.  Effects of Percent Thresholding on the Extraction of [18F]Fluorodeoxyglucose Positron Emission Tomographic Region-of-Interest Data , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  C. Nahmias,et al.  Dopamine visualized in the basal ganglia of living man , 1983, Nature.

[14]  N. Volkow,et al.  Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioning. , 1991, IEEE transactions on medical imaging.

[15]  T Jones,et al.  Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[16]  J R Moeller,et al.  The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies , 1990, Movement disorders : official journal of the Movement Disorder Society.

[17]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  M. Phelps,et al.  Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  E. Hoffman,et al.  A BOUNDARY METHOD FOR ATTENUATION CORRECTION IN POSITRON COMPUTED TOMOGRAPHY , 1981, Journal of Nuclear Medicine.

[20]  C D Marsden,et al.  Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.

[21]  S. Huang,et al.  The effects of measurement errors in the plasma radioactivity curve on parameter estimation in positron emission tomography. , 1991, Physics in medicine and biology.